IL1B and breast carcinoma: It has been shown by Jeon M et al. (2016) that inhibition of IL-1β expression decreased invasiveness of breast cancer cells through suppression of NFκB activity (31) whereas overexpression of IL-1β in metastatic bladder cancer cells is found responsible for the invasion (32).